Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ranitidine 8mg/5ml oral liquid
0103010T0AAAUAU
|
Ranitidine hydrochloride | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitidine bismuth citrate 400mg tablets
0103010S0AAAAAA
|
Ranitidine bismuth citrate | Ranitidine bismuth citrate | Gastro-Intestinal System | No data available |
|
Ranitil 150mg tablets
0103010T0BJAAAA
|
Ranitil | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranitil 300mg tablets
0103010T0BJABAC
|
Ranitil | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Rantec 300 tablets
0103010T0BGABAC
|
Rantec | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Ranzac 75mg tablets
0103010T0BKAAAP
|
Ranzac | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
|
Regulan 3.4g oral powder sachets lemon & lime
0106010E0BEABAJ
|
Regulan | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Regulan 3.4g oral powder sachets orange
0106010E0BEACAJ
|
Regulan | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Regulose 3.1-3.7g/5ml syrup
0106040G0BFAAAA
|
Regulose | Lactulose | Gastro-Intestinal System | No data available |
|
Relaxyl 60mg capsules
0102000A0BCAAAA
|
Relaxyl | Alverine citrate | Gastro-Intestinal System | No data available |
|
Relistor 12mg/0.6ml solution for injection vials
0106060A0BBAAAA
|
Relistor | Methylnaltrexone bromide | Gastro-Intestinal System | No data available |
|
Remegel 800mg chewable tablets mint
0101021C0BFAABX
|
Remegel | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Remegel Summer Fruit 800mg chewable tablets
0101021C0BFADBX
|
Remegel | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Remegel Wind Relief chewable tablets
0101010S0BBAAAA
|
Remegel Wind Relief | Calcium carbonate and simeticone | Gastro-Intestinal System | No data available |
|
Rennie Dual Action Liquid oral suspension
0101021B0BJAAAN
|
Rennie (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Rennie Fruit 500mg tablets
0101021C0BEABAF
|
Rennie Rap-Eze | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Rennie Heartburn, Indigestion and Wind Relief chewable tab
010102100BBBGAB
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Rennie Soft Chews 800mg chewable tablets
0101021C0BIAABX
|
Rennie | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Risankizumab 360mg/2.4ml solution for injection cartridges
0105030C0AAAAAA
|
Risankizumab | Risankizumab | Gastro-Intestinal System | No data available |
|
Robinul 1mg tablets
0102000L0BBACAC
|
Robinul (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | No data available |
|
Robinul Forte 2mg tablets
0102000L0BBABAA
|
Robinul (Oral) | Glycopyrronium bromide | Gastro-Intestinal System | No data available |
|
S-Bicarb SF 420mg/5ml (1mmol/ml) oral solution
0101012B0BGAAAB
|
S-Bicarb SF | Sodium bicarbonate | Gastro-Intestinal System | No data available |
|
Salazopyrin 250mg/5ml oral suspension
0105010E0BBAEAE
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | No data available |
|
Salazopyrin 3g/100ml enema
0105010E0BBADAD
|
Salazopyrin | Sulfasalazine | Gastro-Intestinal System | No data available |
|
Senease Eighteen Years Plus 7.5mg tablets
0106020V0BDAAAA
|
Senease | Sennosides | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.